InsiderFlow

Matthew E Korenberg

LGND

Matthew E Korenberg serves as President & COO at Ligand Pharmaceuticals Incorporated (LGND). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$6.92M

Net Position

Net Seller

$6.92M

Companies Traded

1

LGND

Active Period

May 2024 – Sep 2024

4 total trades

Most Recent

Sell LGND

Sep 24, 2024 · $1.64M

Matthew E Korenberg's Insider Trading at Ligand Pharmaceuticals Incorporated (LGND)

Buys

0 · $0.00

Sells

4 · $6.92M

Total Shares Bought

0

Total Shares Sold

70,748

LGND Price Chart
Loading chart...
DateTypeValue
Sep 24, 2024 Sell$1.64M
Aug 26, 2024 Sell$1.99M
Aug 13, 2024 Sell$1.80M
May 15, 2024 Sell$1.50M